
    
      A Open-label, Single-center Study to Assess the Effect of the CYP3A4 Inhibitor Itraconazole
      and the CYP2C19 Inhibitor Fluconazole on the Pharmacokinetics of a 25 mg Single Oral Dose of
      Selumetinib (AZD6244; ARRY-142866) ( Hyd-Sulfate) in Healthy Volunteers
    
  